Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

September 23, 2025

Study Completion Date

December 25, 2025

Conditions

Contrast Enhanced Images vs. Non-contrast ImagesGadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images

Interventions

DRUG

Gadopiclenol

The enhanced images by Gadopiclenol and Gadobutrol will be compared.

DRUG

Gadobutrol (Gadavist, BAY86-4875)

Gadobutrol will be used as a comparator

Trial Locations (1)

RECRUITING

University of Connecticut Health Center, Farmington

All Listed Sponsors

lead

UConn Health

OTHER